Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$1.75 - $11.34 $34,007 - $220,370
-19,433 Closed
0 $0
Q1 2022

May 10, 2024

BUY
$10.21 - $20.29 $198,410 - $394,295
19,433 New
19,433 $198,000
Q1 2022

Jun 20, 2023

BUY
$10.21 - $20.29 $198,410 - $394,295
19,433 New
19,433 $198,000
Q1 2022

Mar 22, 2023

BUY
$10.21 - $20.29 $64,731 - $128,638
6,340 Added 48.42%
19,433 $198,000
Q1 2022

May 12, 2022

BUY
$10.21 - $20.29 $64,731 - $128,638
6,340 Added 48.42%
19,433 $198,000
Q4 2021

May 17, 2024

BUY
$16.76 - $22.99 $37,777 - $51,819
2,254 Added 20.8%
13,093 $257,000
Q4 2021

Jun 21, 2023

BUY
$16.76 - $22.99 $219,438 - $301,008
13,093 New
13,093 $257,000
Q4 2021

Mar 22, 2023

BUY
$16.76 - $22.99 $37,777 - $51,819
2,254 Added 20.8%
13,093 $257,000
Q4 2021

Feb 15, 2022

BUY
$16.76 - $22.99 $37,777 - $51,819
2,254 Added 20.8%
13,093 $258,000
Q3 2021

Jun 21, 2023

BUY
$13.15 - $22.56 $142,532 - $244,527
10,839 New
10,839 $200,000
Q2 2021

May 17, 2024

BUY
$18.28 - $33.05 $103,154 - $186,501
5,643 Added 108.6%
10,839 $198,000
Q2 2021

Mar 22, 2023

BUY
$18.28 - $33.05 $103,154 - $186,501
5,643 Added 108.6%
10,839 $198,000
Q2 2021

Aug 16, 2021

BUY
$18.28 - $33.05 $103,154 - $186,501
5,643 Added 108.6%
10,839 $198,000
Q1 2021

May 17, 2024

BUY
$29.34 - $60.2 $152,450 - $312,799
5,196 New
5,196 $170,000
Q1 2021

Jun 26, 2023

BUY
$29.34 - $60.2 $152,450 - $312,799
5,196 New
5,196 $170 Million
Q4 2020

May 24, 2024

BUY
$27.25 - $55.82 $141,591 - $290,040
5,196 New
5,196 $285,000
Q4 2020

Jun 22, 2023

BUY
$27.25 - $55.82 $141,591 - $290,040
5,196 New
5,196 $285,000
Q4 2020

Mar 22, 2023

BUY
$27.25 - $55.82 $141,591 - $290,040
5,196 New
5,196 $285,000
Q4 2020

Feb 16, 2021

BUY
$27.25 - $55.82 $141,591 - $290,040
5,196 New
5,196 $286,000

Others Institutions Holding PRAX

# of Institutions
1
Shares Held
75K
Call Options Held
0
Put Options Held
0

About Praxis Precision Medicines, Inc.


  • Ticker PRAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,576,100
  • Market Cap $2.62B
  • Description
  • Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...
More about PRAX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.